Latest Articles
'I'm fighting for time': Paramedic diagnosed with stage 4 metastatic cancer after visiting GP 21 times - portsmouth.co.uk
'I'm fighting for time': Paramedic diagnosed with stage 4 metastatic cancer after visiting GP 21 times portsmouth.co.uk
Published: May 30, 2026, 4:01 p.m.
'I'm fighting for time': Paramedic diagnosed with stage 4 metastatic cancer after visiting GP 21 times with symptoms - portsmouth.co.uk
'I'm fighting for time': Paramedic diagnosed with stage 4 metastatic cancer after visiting GP 21 times with symptoms portsmouth.co.uk
Published: May 30, 2026, 4:01 p.m.
18-year-old's openness about endometriosis leads to regional first, growing momentum - PembinaValleyOnline
18-year-old's openness about endometriosis leads to regional first, growing momentum PembinaValleyOnline
Published: May 30, 2026, 10:04 a.m.
Weight loss drugs show promise in breast cancer fight — plus more medical headlines - AOL.com
Weight loss drugs show promise in breast cancer fight — plus more medical headlines AOL.com
Published: May 30, 2026, 9:02 a.m.
"The disease took everything from me": This athlete opens up about her battle against endometriosis - MSN
"The disease took everything from me": This athlete opens up about her battle against endometriosis MSN
Published: May 30, 2026, 5:22 a.m.
Menstrual blood may help detect endometriosis without surgery new study reveals - TheHealthSite
Menstrual blood may help detect endometriosis without surgery new study reveals TheHealthSite
Published: May 30, 2026, 5:13 a.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor
Published: May 30, 2026, 4 a.m.
First responders continue recovery two weeks after deadly Robbins Lumber explosion - newscentermaine.com
First responders continue recovery two weeks after deadly Robbins Lumber explosion newscentermaine.com
Published: May 30, 2026, 12:38 a.m.
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer - OncLive
Long-Term RUBY Data Show Potential for Curative Intent With Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer OncLive
Published: May 30, 2026, 12:24 a.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive
Published: May 29, 2026, 11:57 p.m.
Link copied to clipboard!